Introduction
Evaluating amateur and professional athletes before sports participation ensures their health before competing. Many sports associations and leagues require a health examination and documentation of clinical findings to maximize safe participation and identify medical problems with risks of life-threatening complications that limit or exclude play. Many professional groups make specific recommendations, including the American Academy of Pediatrics, the American Academy of Family Physicians, the American College of Sports Medicine, the American Society for Sports Medicine, the American Orthopedic Society for Sports Medicine, the American Osteopathic Society for Sports Medicine, the American Heart Association, and the European Society of Cardiology.[1]
The assessment is not intended to replace comprehensive health maintenance or well-child visits but rather to identify medical problems that might result in severe complications during play, conditions that require a treatment plan or rehabilitation before participation, and other concerns that unnecessarily restrict athletes from joining a sport. The necessary components are the personal and family medical history, a thorough review of systems, a targeted physical examination, diagnostic studies or referrals when indicated, and a recommendation for full, limited, or no participation.[2][3] A standardized form to document these findings, endorsed by most professional organizations, can be found at the American Academy of Pediatrics website.[2]
Practical considerations include the timing, frequency, and setting of the examination. The ideal time is four to six weeks before the sports season begins. Usually, assessments are required for each new level of school, such as middle school, high school, and university, with yearly updates in between. When conducted in an office setting, the advantages are patient privacy and continuity of care with primary care clinicians. The alternative is the station approach with multiple examiners. This can be time efficient, sports-oriented, less costly, and effective at identifying abnormalities but lacks privacy and continuity of care.
The following details the essential elements of the pre-participation evaluation and recommendations regarding specific abnormal findings.
Function
Register For Free And Read The Full Article
- Search engine and full access to all medical articles
- 10 free questions in your specialty
- Free CME/CE Activities
- Free daily question in your email
- Save favorite articles to your dashboard
- Emails offering discounts
Learn more about a Subscription to StatPearls Point-of-Care
Function
The primary purpose of the sports pre-participation evaluation is to screen for underlying medical conditions and to ensure the athlete is in optimal health for the chosen sport. The athlete's personal and family medical history identifies most conditions that restrict participation or require further evaluation. The following are critical components of the history, review of systems, and physical examination.
Personal Medical History
- Cardiovascular conditions with increased risk of sudden death, including hypertension, heart murmur, Kawasaki disease, myocarditis, unexplained syncope, and unexplained seizures[4]
- Previous injuries, including musculoskeletal trauma and concussions, primarily if they resulted in being excluded from play
- Recent significant weight gain or loss and athlete's perception of current weight
- Prior heat-related illness
- Recent serious infections, including COVID-19
- Loss of function of a paired organ, such as the eye, testis, or kidney
- Menstrual history in females
Family Medical History
- Death or disability from cardiac causes, including unexplained sudden death in a close family member younger than 50 years of age and unexplained drowning
- Heritable cardiomyopathies or arrhythmia syndromes, such as hypertrophic cardiomyopathy and prolonged QT, presence of a pacemaker or implanted defibrillator, and Marfan syndrome [5]
- Undiagnosed syncope
- Muscular dystrophies
Current Medications, Supplements, and Substance Use
Athletes commonly use health and nutritional supplements. Some supplements contain ingredients that pose a health risk and are banned from use by the World Anti-Doping Agency (WADA). Also, certain supplements, such as specific stimulants, may be legal but pose long-term cumulative health risks when used in high doses. Performance-enhancing drugs (PEDs) and recreational substances are cause for concern in athletes. PEDs are highly sport-specific, with the most commonly used ones categorized as anabolic agents and stimulants. Anabolic drugs are classified as anabolic-androgenic steroids (AAS) and peptide hormones. Prescribed medications should be reviewed due to the potential for causing athletes to fail a drug test or affecting their performance.[6]
Immunizations
Sports participation is a mechanism for spreading vaccine-preventable communicable infections. Athletes are at risk due to shared travel spaces, food, water bottles, and equipment, as well as potential close exposure to body fluids and travel to at-risk locales. Clinicians should ensure that routine nationally recommended vaccines are up to date and protect players by administering immunizations appropriate for specific geographic locations and the season, including influenza and COVID-19.[7]
Review of Systems
- Cardiac: Syncope, presyncope, dizziness, dyspnea or chest pain with exercise, palpitations
- Respiratory: Dyspnea not related to asthma or poor conditioning
- Neurological: Headaches, difficulty concentrating, sleep problems, or fatigue that might be mistaken for concussion symptoms, and seizures
- Musculoskeletal: Joint pain, stiffness, limited range of motion of extremities, hypermobility, chronic back pain
- Hematologic: Excessive bleeding, easy bruising, or menorrhagia
- Psychiatric: Symptoms of depression or other mood disorders that may result in less-than-optimal performance or conditions that could be exacerbated by the mental and physical stress of competitive sports
Physical Examination
The complete physical examination begins with assessing vital signs and then targets the cardiovascular, respiratory, musculoskeletal, and neurological systems. Elevated blood pressure and bradycardia should be noted. Many healthy athletes have a low resting heart rate, which is usually of no concern but may suggest inadequate caloric intake associated with an eating disorder. Body weight and body mass index (BMI) may indicate the need for further investigation. A low BMI or body fat percentage may suggest rapid weight loss in wrestlers ("cutting") or an eating disorder, especially in female athletes.
- Eyes: Protective eyewear is recommended if the best-corrected vision is less than 20/40, especially for basketball.
- Skin: Evidence of contagious infections such as tinea corporis, scabies, molluscum contagiosum, and impetigo disqualifies athletes in sports with close physical contact or shared equipment like gymnastics mats.
- Respiratory: Evidence of wheezing may be associated with poorly controlled asthma.
- Cardiovascular: Irregular rhythm, murmurs, S3, or S4 on auscultation must be evaluated. Heaves, lifts, or thrills may indicate a previously undiagnosed cardiac condition. Absent femoral pulses suggest coarctation of the aorta.
- Abdomen: Organomegaly is a disqualification for contact sports participation.
- Genitourinary: The presence of a solitary testis requires the use of a protective athletic cup, especially in contact sports. Tanner staging for biological maturity may aid athletes in choosing sports in which they are likely to succeed.
- Musculoskeletal: The examination should highlight high-risk areas such as shoulders, knees, and ankles. Arachnodactyly and pectus chest deformities are associated with Marfan Syndrome. Prominent tibial tuberosities are present in Osgood-Schlatter's disease. Patients with Ehlers-Danlos Syndrome may exhibit joint hypermobility.
Further Evaluation
For healthy athletes without symptoms, no routine laboratory studies are recommended. Evaluation should be individualized, such as obtaining a complete blood count to look for anemia if evidence of malnutrition is present. Electrocardiograms and echocardiograms are not indicated in the absence of clinical concerns. Unnecessary diagnostic tests may result in false-positive findings and lead to further invasive testing, which is costly and may cause harm and anxiety to the patient.
- Electrocardiogram (ECG): The decision to undergo testing should be discussed between the physician and the patient. It is critical to distinguish between abnormal ECG findings within the general population and expected results in athletes. Concerning findings in athletes include accessory pathways, short PR intervals, long or short QT intervals, epsilon waves, T-wave inversions, and excessive premature ventricular contractions. Normal ECG findings in athletes include bradycardia, sinus arrhythmia, ventricular enlargement, and first-degree atrioventricular block. Distinguishing benign and pathologic findings can reduce unnecessary diagnostic testing and treatments.[8] Consulting cardiologists often perform echocardiography when clinically significant conditions are diagnosed.
- Consultations: Besides cardiologists, examining clinicians refer patients to other specialists when indicated. An example is consulting with a nephrologist before a patient with a solitary kidney plays contact sports since that is a possible contraindication to participation. Patients with eating disorders benefit from gynecologic and nutrition consultations.
Consequences of the Evaluation
- Most healthy young athletes are fully cleared for sports participation.
- For athletes who are not cleared, they may be able to safely play with limitations, such as excluding contact sports. Others may be temporarily banned. Players with febrile illnesses must wait until the resolution of any infectious process for their health and to prevent the disease from spreading to teammates. The COVID-19 pandemic resulted in new, changing restrictions, and clinicians should check current professional and public health guidelines. Before returning to play, a physician should clear patients with more than mild COVID-19 illness. Patients with severe symptoms like multi-system inflammatory syndrome should be restricted from sports for three to six months and evaluated by a cardiologist before returning to play. Uncontrolled hypertension is a condition that prevents participation, and treatment may need to be modified since some diuretics and beta blockers are prohibited by various sports. Patients with sickle cell trait are at increased risk of sudden death during strenuous exercise and require anticipatory interventions to prevent hyperthermia and dehydration.
- It is unusual for athletes to be permanently excluded from all sports. In those cases, clinicians should provide explanations and empathy and, if possible, guide patients toward safe activities to receive the benefits of exercise and socialization that sports offer.
Clinical Significance
The likelihood of sudden cardiac arrest is minimal in athletes, at less than one per 100,000 athlete-years.[9] Athletes who experience possible cardiac symptoms, especially episodes of unexplained syncope, may be at risk. However, the differential diagnosis for syncope in athletes includes non-cardiac causes, such as vasovagal events, heatstroke, dehydration, and blunt trauma. A comprehensive sports participation evaluation can reassure athletes and their families that they are at low risk of sudden cardiac arrest, death, or other predictable injury.
Cardiac Conditions Associated With Cardiac Arrest in Athletes
- Hypertrophic Obstructive Cardiomyopathy (the most common cause of sudden death in young athletes)[10][11][12]
- Coronary Artery Anomaly (the second most common cause of sudden death in young athletes)
- Coronary Artery Disease (the most common overall cause of death in athletes of any age due to its relatively high prevalence among older athletes)[13]
- Arrhythmias such as ventricular tachycardia are among the most frequent causes of sudden death.[14][13]
- Anabolic Steroid Induced Cardiac Disease, including left ventricular hypertrophy[15]
- Arrhythmogenic Right Ventricular Dysplasia
- Dilated Cardiomyopathy
- Left Ventricular Noncompaction
- Congenital Long QT Syndrome
- Short QT Syndrome
- Brugada Syndrome
- Wolff Parkinson White Syndrome
- Catecholaminergic Polymorphic Ventricular Tachycardia
- Early Repolarization Syndrome
- Myocarditis
- Commotio Cordis associated with sudden chest wall impact, usually in contact sports
Other Conditions Associated With Injury
Beyond assessing the risk of sudden death, general harm to individual athletes should be evaluated based on their medical history and chosen sport.
- Concussion history and the risk of neurological harm and chronic traumatic encephalopathy in contact sports
- Rheumatologic disease and the forced stresses induced upon already damaged soft tissues
- Orthopedic injuries and ensuring optimal recovery of prior trauma before returning to competitive sports
- Hematologic disorders that may lead to internal organ bleeding or significant blood loss after blunt trauma or lacerations
PEDs and Associated Health Risks
- Anabolic steroids induce many symptoms and illnesses, which may increase the long-term risk of early mortality.
- Peptide hormones may lead to cardiac structural changes that are tied to cardiac arrest and increase the risk of cancers.
- Stimulants can lead to long-term cardiovascular damage and increase the risk of both benign and dangerous arrhythmias.[16]
Other Issues
Frequently, teenagers report concussion-like symptoms without a history of head trauma. These include fatigue, sleep problems, difficulty concentrating, and headaches. A standardized sports concussion assessment tool like the SCAT-3 before contact sports can help distinguish concussion symptoms after injury from a patient's baseline report and prevent players from being unnecessarily excluded from participation.[17]
The American Academy of Pediatrics suggests inquiring about many additional relevant topics during the sports examination. This is more likely to occur when the pre-participation evaluation occurs in an office rather than a station setting. Even then, time constraints may limit a discussion of the following subjects:
- Stress and pressure the athlete may be experiencing
- Symptoms of depression and administering a standardized screening tool like the Patient Health Questionnaire (PHQ-9)
- Whether or not the athlete feels safe at home
- Tobacco or any substance use
- Substances or supplements intended to promote weight gain or loss
- Seat belt use and general safety measures
Enhancing Healthcare Team Outcomes
Clinicians and healthcare workers should take an interprofessional team-based approach to ensure safe participation in sports. Primary care clinicians, including physicians, physician assistants, and nurse practitioners, can screen athletes for significant medical issues. Pharmacists play a role as educators and assist the clinical team with reviewing medications and substances. The unnecessary use of nutritional and health supplements can be avoided if athletes are informed and have ready access to consulting pharmacists and registered dietitians.
The interprofessional team approach is well-suited to pre-participation examinations in a setting with multiple stations to evaluate players. Nurses can assist with history taking, vital signs, recording growth charts and BMI data, performing parts of the physical examination, completing health forms, coordinating referrals to specialists, and answering patient and family questions. An interprofessional team approach will likely result in the best clinical outcomes for athletes.
References
Maron BJ, Levine BD, Washington RL, Baggish AL, Kovacs RJ, Maron MS, American Heart Association Electrocardiography and Arrhythmias Committee of Council on Clinical Cardiology, Council on Cardiovascular Disease in Young, Council on Cardiovascular and Stroke Nursing, Council on Functional Genomics and Translational Biology, and American College of Cardiology. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 2: Preparticipation Screening for Cardiovascular Disease in Competitive Athletes: A Scientific Statement From the American Heart Association and American College of Cardiology. Circulation. 2015 Dec 1:132(22):e267-72. doi: 10.1161/CIR.0000000000000238. Epub 2015 Nov 2 [PubMed PMID: 26527714]
Lick D, Abdel-Aty K, Diaz D, Dulku J, Lochub S, Mir K, Ricketts R. Preparticipation Sports Physicals: A Comparison of Single Provider and Station-Based Models. Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine. 2018 Nov:28(6):530-532. doi: 10.1097/JSM.0000000000000473. Epub [PubMed PMID: 28708703]
Lehman PJ, Carl RL. The Preparticipation Physical Evaluation. Pediatric annals. 2017 Mar 1:46(3):e85-e92. doi: 10.3928/19382359-20170222-01. Epub [PubMed PMID: 28287681]
Pigolkin YI, Shilova MA, Zakharov SN, Sereda AP, Zholinskiy AV, Kruglova IV, Shigeev SV. [The sudden death among the young persons under effect of the different forms of physical loads]. Sudebno-meditsinskaia ekspertiza. 2019:62(1):50-55. doi: 10.17116/sudmed20196201150. Epub [PubMed PMID: 30724895]
Ison HE, Ware SM, Schwantes-An TH, Freeze S, Elmore L, Spoonamore KG. The impact of cardiovascular genetic counseling on patient empowerment. Journal of genetic counseling. 2019 Jun:28(3):570-577. doi: 10.1002/jgc4.1050. Epub 2019 Jan 24 [PubMed PMID: 30680842]
Horwitz H, Andersen JT, Dalhoff KP. Health consequences of androgenic anabolic steroid use. Journal of internal medicine. 2019 Mar:285(3):333-340. doi: 10.1111/joim.12850. Epub 2018 Nov 20 [PubMed PMID: 30460728]
Boston CD, Bryan JJ. Immunizations in Athletes. Sports health. 2018 Sep/Oct:10(5):427-433. doi: 10.1177/1941738118788279. Epub 2018 Jul 30 [PubMed PMID: 30059267]
Basu J, Malhotra A. Interpreting the Athlete's ECG: Current State and Future Perspectives. Current treatment options in cardiovascular medicine. 2018 Nov 19:20(12):104. doi: 10.1007/s11936-018-0693-0. Epub 2018 Nov 19 [PubMed PMID: 30456469]
Level 3 (low-level) evidenceLandry CH, Allan KS, Connelly KA, Cunningham K, Morrison LJ, Dorian P, Rescu Investigators. Sudden Cardiac Arrest during Participation in Competitive Sports. The New England journal of medicine. 2017 Nov 16:377(20):1943-1953. doi: 10.1056/NEJMoa1615710. Epub [PubMed PMID: 29141175]
van Driel B, Asselbergs FW, de Boer RA, van Rossum AC, van Tintelen JP, van der Velden J, Michels M. [Hypertrophic cardiomyopathy]. Nederlands tijdschrift voor geneeskunde. 2019 Feb 7:163():. pii: D2790. Epub 2019 Feb 7 [PubMed PMID: 30730688]
Maron BJ, Shirani J, Poliac LC, Mathenge R, Roberts WC, Mueller FO. Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles. JAMA. 1996 Jul 17:276(3):199-204 [PubMed PMID: 8667563]
Finocchiaro G, Papadakis M, Robertus JL, Dhutia H, Steriotis AK, Tome M, Mellor G, Merghani A, Malhotra A, Behr E, Sharma S, Sheppard MN. Etiology of Sudden Death in Sports: Insights From a United Kingdom Regional Registry. Journal of the American College of Cardiology. 2016 May 10:67(18):2108-2115. doi: 10.1016/j.jacc.2016.02.062. Epub [PubMed PMID: 27151341]
Eckart RE, Shry EA, Burke AP, McNear JA, Appel DA, Castillo-Rojas LM, Avedissian L, Pearse LA, Potter RN, Tremaine L, Gentlesk PJ, Huffer L, Reich SS, Stevenson WG, Department of Defense Cardiovascular Death Registry Group. Sudden death in young adults: an autopsy-based series of a population undergoing active surveillance. Journal of the American College of Cardiology. 2011 Sep 13:58(12):1254-61. doi: 10.1016/j.jacc.2011.01.049. Epub [PubMed PMID: 21903060]
Level 2 (mid-level) evidenceCorrado D, Basso C, Schiavon M, Thiene G. Screening for hypertrophic cardiomyopathy in young athletes. The New England journal of medicine. 1998 Aug 6:339(6):364-9 [PubMed PMID: 9691102]
Chistiakov DA, Myasoedova VA, Melnichenko AA, Grechko AV, Orekhov AN. Role of androgens in cardiovascular pathology. Vascular health and risk management. 2018:14():283-290. doi: 10.2147/VHRM.S173259. Epub 2018 Oct 15 [PubMed PMID: 30410343]
Farzam K, Richards JR. Premature Ventricular Contraction. StatPearls. 2023 Jan:(): [PubMed PMID: 30422584]
Caccese JB, Garcia GP, Kontos AP, Port N, Valerio K, Broglio SP, McCrea M, McAllister TW, Pasquina PF, Buckley TA, CARE Consortium Investigators. Test-Retest Reliability and Efficacy of Individual Symptoms in Concussion Management. Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine. 2023 Jan 1:33(1):52-60. doi: 10.1097/JSM.0000000000001084. Epub 2022 Nov 6 [PubMed PMID: 36599360]